SCHEMBL4474152

SCHEMBL4474152

COc1cc(C)ccc1C(=O)NNC(=S)S

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.55
NPC1 O15118 7/20 0.55
STAT3 P40763 1/20 0.49
MAPT P10636 4/20 0.48
GAA P10253 3/20 0.48
KDM4E B2RXH2 3/20 0.48
SMN1; SMN2 Q16637 5/20 0.47
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
EPHX1 P07099 1/20 0.46
POLB P06746 1/20 0.46
LMNA P02545 2/20 0.46
HTT P42858 1/20 0.45
KCNMA1 Q12791 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4483750 0.84 RAB9A (0.52) RAB9ANPC1STAT3MAPTGAA
SCHEMBL13294935 0.79 HDAC7 (0.53) RAB9ANPC1STAT3MAPTGAA
SCHEMBL1003770 0.79 PLK1 (0.54) RAB9ANPC1MAPTGAAKDM4E
SCHEMBL6829957 0.79 ACHE (0.52) RAB9ANPC1MAPTGAAKDM4E
SCHEMBL4502457 0.78 NPC1 (0.56) RAB9ANPC1STAT3MAPTGAA
SCHEMBL4333687 0.78 CTSD (0.67) RAB9ANPC1MAPTGAAKDM4E
SCHEMBL6739693 0.77 RAB9A (0.50) RAB9ANPC1STAT3MAPTGAA
SCHEMBL136101 0.75 MAPT (0.60) RAB9ANPC1MAPTGAAKDM4E
SCHEMBL2479959 0.75 RAB9A (0.48) RAB9ANPC1MAPTGAAKDM4E
SCHEMBL4527088 0.75 RAB9A (0.57) RAB9ANPC1STAT3MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009094205-A2 3-ARYL-6-ARYL-7H-[1,2,4]TRIAZOLO[3,4-B][1,3,4]THIADIAZINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA, INC. (US) 2009-07-30 WO disclosed